[1]
Periago MV,García R,Astudillo OG,Cabrera M,Abril MC, Prevalence of intestinal parasites and the absence of soil-transmitted helminths in Añatuya, Santiago del Estero, Argentina. Parasites & vectors. 2018 Dec 14
[PubMed PMID: 30547815]
[2]
Lalle M,Hanevik K, Treatment-refractory giardiasis: challenges and solutions. Infection and drug resistance. 2018
[PubMed PMID: 30498364]
[3]
Ryan U,Hijjawi N,Feng Y,Xiao L, Giardia: an under-reported foodborne parasite. International journal for parasitology. 2019 Jan
[PubMed PMID: 30391227]
[4]
Boutrid N,Rahmoune H,Amrane M, Genetics and serology of celiac disease during giardiasis. Scandinavian journal of gastroenterology. 2018 Oct 24;
[PubMed PMID: 30353768]
[5]
Vivancos V,González-Alvarez I,Bermejo M,Gonzalez-Alvarez M, Giardiasis: Characteristics, Pathogenesis and New Insights About Treatment. Current topics in medicinal chemistry. 2018;
[PubMed PMID: 30277155]
[6]
Horton B,Bridle H,Alexander CL,Katzer F, Giardia duodenalis in the UK: current knowledge of risk factors and public health implications. Parasitology. 2019 Apr
[PubMed PMID: 30318029]
[7]
Reses HE,Gargano JW,Liang JL,Cronquist A,Smith K,Collier SA,Roy SL,Vanden Eng J,Bogard A,Lee B,Hlavsa MC,Rosenberg ES,Fullerton KE,Beach MJ,Yoder JS, Risk factors for sporadic Giardia infection in the USA: a case-control study in Colorado and Minnesota. Epidemiology and infection. 2018 Jul
[PubMed PMID: 29739483]
Level 2 (mid-level) evidence
[8]
Zajaczkowski P,Mazumdar S,Conaty S,Ellis JT,Fletcher-Lartey SM, Epidemiology and associated risk factors of giardiasis in a peri-urban setting in New South Wales Australia. Epidemiology and infection. 2018 Sep 28
[PubMed PMID: 30264685]
[9]
Coffey CM,Collier SA,Gleason ME,Yoder JS,Kirk MD,Richardson AM,Fullerton KE,Benedict KM, Evolving epidemiology of reported giardiasis cases in the United States, 1995-2016. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Feb 12
[PubMed PMID: 32047932]
Level 3 (low-level) evidence
[10]
Leung AKC,Leung AAM,Wong AHC,Sergi CM,Kam JKM, Giardiasis: An Overview. Recent patents on inflammation & allergy drug discovery. 2019
[PubMed PMID: 31210116]
Level 3 (low-level) evidence
[11]
Müller J,Hemphill A,Müller N, Physiological aspects of nitro drug resistance in Giardia lamblia. International journal for parasitology. Drugs and drug resistance. 2018 Aug
[PubMed PMID: 29738984]
[12]
Currie SL,Stephenson N,Palmer AS,Jones BL,Hawkins G,Alexander CL, Under-reporting giardiasis: time to consider the public health implications. Epidemiology and infection. 2017 Oct
[PubMed PMID: 28879824]
[13]
Norman FF,Comeche B,Chamorro S,Pérez-Molina JA,López-Vélez R, Update on the major imported protozoan infections in travelers and migrants. Future microbiology. 2020 Feb 17
[PubMed PMID: 32065535]
[14]
Escobedo AA,Acosta-Ballester G,Almirall P,Rodriguez-Morales AJ,Ortíz C,Laffita A,Chirino E, Potential sexual transmission of Giardia in an endemic region: a case series. Le infezioni in medicina. 2018 Jun 1
[PubMed PMID: 29932093]
Level 2 (mid-level) evidence
[15]
Pietrzak A,Chodorowska G,Urban J,Bogucka V,Dybiec E, Cutaneous manifestation of giardiasis - case report. Annals of agricultural and environmental medicine : AAEM. 2005
[PubMed PMID: 16457489]
Level 3 (low-level) evidence
[16]
Weisz F,Lalle M,Nohynkova E,Sannella AR,Dluhošová J,Cacciò SM, Testing the impact of Whole Genome Amplification on genome comparison using the polyploid flagellated Giardia duodenalis as a model. Experimental parasitology. 2019 Dec
[PubMed PMID: 31628895]
[17]
Jangra M,Dutta U,Shah J,Thapa BR,Nada R,Gupta N,Sehgal R,Sharma V,Khurana S, Role of Polymerase Chain Reaction in Stool and Duodenal Biopsy for Diagnosis of Giardiasis in Patients with Persistent/Chronic Diarrhea. Digestive diseases and sciences. 2020 Aug
[PubMed PMID: 31955285]
[19]
Stallmach A,Hagel S,Lohse AW, [Diagnostic workup and therapy of infectious diarrhea. Current standards]. Der Internist. 2015 Dec
[PubMed PMID: 26573083]
[20]
Iza JA,Iza SN,Olivera MJ, Giardiasis: report of a case refractory to treatment. Le infezioni in medicina. 2019 Sep 1
[PubMed PMID: 31545780]
Level 3 (low-level) evidence
[21]
Krueger A,Schulkin J,L Jones J, Survey of obstetrician-gynecologists about giardiasis. Infectious diseases in obstetrics and gynecology. 2007
[PubMed PMID: 17710238]
Level 3 (low-level) evidence
[22]
Escobedo AA,Almirall P,Chirino E,Pacheco F,Duque A,Avila I, Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: a case series. Le infezioni in medicina. 2018 Dec 1
[PubMed PMID: 30555145]
Level 2 (mid-level) evidence
[23]
Zhen Y,Liao L,Zhang H, Intestinal Giardiasis Disguised as Ulcerative Colitis. Case reports in gastrointestinal medicine. 2018
[PubMed PMID: 29854495]
Level 3 (low-level) evidence
[24]
Sebastián Domingo JJ, Irritable Bowel Syndrome with predominant diarrhea and giardiasis: is it one or the other? Gastroenterologia y hepatologia. 2018 Dec
[PubMed PMID: 29500067]
[25]
Litleskare S,Rortveit G,Eide GE,Emberland KE,Hanevik K,Langeland N,Wensaas KA, Quality of life and its association with irritable bowel syndrome and fatigue ten years after giardiasis. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society. 2019 May
[PubMed PMID: 30767352]
Level 2 (mid-level) evidence
[26]
Adeyemo FE,Singh G,Reddy P,Bux F,Stenström TA, Efficiency of chlorine and UV in the inactivation of Cryptosporidium and Giardia in wastewater. PloS one. 2019
[PubMed PMID: 31083664]
[27]
Nakao JH,Collier SA,Gargano JW, Giardiasis and Subsequent Irritable Bowel Syndrome: A Longitudinal Cohort Study Using Health Insurance Data. The Journal of infectious diseases. 2017 Mar 1;
[PubMed PMID: 28329069]
[28]
Beer KD,Collier SA,Du F,Gargano JW, Giardiasis Diagnosis and Treatment Practices Among Commercially Insured Persons in the United States. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 May 1;
[PubMed PMID: 28207070]
[29]
Escobedo AA,Almirall P,González-Fraile E,Ballesteros J, Efficacy of mebendazole in paediatric patients with giardiasis: A systematic review and meta-analysis. Acta tropica. 2018 Dec;
[PubMed PMID: 30092225]
Level 1 (high-level) evidence
[30]
Daly ER,Roy SJ,Blaney DD,Manning JS,Hill VR,Xiao L,Stull JW, Outbreak of giardiasis associated with a community drinking-water source. Epidemiology and infection. 2010 Apr;
[PubMed PMID: 19751538]
[31]
Robertson LJ,Forberg T,Gjerde BK, Giardia cysts in sewage influent in Bergen, Norway 15-23 months after an extensive waterborne outbreak of giardiasis. Journal of applied microbiology. 2008 Apr;
[PubMed PMID: 17976168]
[32]
Ryu H,Alum A,Mena KD,Abbaszadegan M, Assessment of the risk of infection by Cryptosporidium and Giardia in non-potable reclaimed water. Water science and technology : a journal of the International Association on Water Pollution Research. 2007;
[PubMed PMID: 17305151]